Urine L-selectin reflects clinical and histological renal disease activity and treatment response in lupus nephritis across multi-ethnicity

There is an urgent need for novel biomarkers in lupus nephritis (LN). We report a non-invasive urinary biomarker, L-selectin, in two independent multi-ethnic cohorts.uL-selectin was tested cross-sectionally in a Chinese cohort (n=255) and a US cohort (n=219) of SLE patients and controls using ELISA. A longitudinal cohort includes 20 active Chinese LN patients.uL-selectin was significantly increased in active LN patients compared to active non-renal SLE, inactive LN, inactive non-renal SLE, chronic kidney disease patients, and healthy controls. uL-selectin positively correlated with global and renal disease activities as well as histological activity index and chronicity index (CI). Low uL-selectin was an independent predictor for high CI. During follow-up, uL-selectin levels decreased significantly in the complete renal remission group.uL-selectin is a novel biomarker of disease activity and renal histopathology in LN across multiple ethnicities. It also reflects treatment response in LN patients during follow up.

[1]  B. Rovin,et al.  Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases. , 2021, Kidney international.

[2]  M. Petri,et al.  Quantitative planar array screen of 1000 proteins uncovers novel urinary protein biomarkers of lupus nephritis , 2020, Annals of the Rheumatic Diseases.

[3]  T. Tuschl,et al.  Comprehensive aptamer-based screening identifies a spectrum of urinary biomarkers of lupus nephritis across ethnicities , 2020, Nature Communications.

[4]  L. Truong,et al.  A Systematic Review of Interpathologist Agreement in Histologic Classification of Lupus Nephritis , 2019, Kidney international reports.

[5]  F. Pieruzzi,et al.  Changing patterns in clinical–histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis , 2018, Annals of the rheumatic diseases.

[6]  Agnes B. Fogo,et al.  Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices. , 2018, Kidney international.

[7]  Gerald McGwin,et al.  Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. , 2012, Arthritis and rheumatism.

[8]  H. Anders,et al.  Lupus nephritis , 2009, Nature Reviews Disease Primers.

[9]  I. Bruce,et al.  Systemic lupus international collaborating clinics renal activity/response exercise: development of a renal activity score and renal response index. , 2008, Arthritis and rheumatism.

[10]  K. Ley,et al.  L‐selectin: mechanisms and physiological significance of ectodomain cleavage , 2005, Journal of cellular and molecular medicine.

[11]  D. Gladman,et al.  Systemic lupus erythematosus disease activity index 2000. , 2002, The Journal of rheumatology.

[12]  P. Pizcueta,et al.  Circulating concentrations of soluble L-selectin (CD62L) in patients with primary Sjögren's syndrome , 2000, Annals of the rheumatic diseases.

[13]  T. Tedder,et al.  Elevated serum L-selectin levels and abnormal regulation of L-selectin expression on leukocytes in atopic dermatitis: soluble L-selectin levels indicate disease severity. , 1999, The Journal of allergy and clinical immunology.

[14]  M. Hochberg,et al.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.

[15]  H. Nagaraja,et al.  Kidney biopsy-based management of maintenance immunosuppression is safe and may ameliorate flare rate in lupus nephritis. , 2019, Kidney international.